You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A Vaccine for Schistosomiasis, "SchistoShield"
SBC: PAI LIFE SCIENCES INC Topic: NIAIDDESCRIPTIONprovided by applicantSchistosomiasis is a major neglected tropical disease of public health concern to a billion people withmillion currently infected andmillion at risk to acquire the infectionthe majority of these in AfricaThe disease has a high impact on affected people s lives with disability adjusted life years atmillion years which ran this malady ahead of malariaCurrent control s ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Overcoming Tramadol Resistance In CYP2D6 Poor Metabolizers:A Phase 1 Trial Demonstrating Analgesic Superiority of Omnitram to Tramadol in Subjects Coadministered Paroxetine
SBC: Syntrix Biosystems, Inc. Topic: NIDADESCRIPTIONprovided by applicantFromthe utilization of the Schedule II opioids codeineOxyContin and fentanyl declined significantlydown aboutfor all three drugsIn sharp contrastthe use of tramadola Schedule IV controlled substanceincreasedSchedule IV substances have low potential for abuse and harm relative to Schedule II substancesand the fortuitous trend to tramadol has reduced the use of the re ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Clonotyping Technology for Prediction of Antibiotic Resistance
SBC: ID GENOMICS SPC Topic: NIAIDDESCRIPTIONprovided by applicantThe primary goal of this proposal is to develop and finalize configuration of a rapid molecular diagnostics test to predict antibiotic resistance of th major human uropathogensEscherichia coliKlebsiella pneumoniaeEnterobacter spp and Pmirabilisby determining the sub species clonal identityclonotypeof the infecting bacteria directly from urine samplesCurrentlythe emp ...
STTR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Kinetic Phenotype Discovery Informatics for Neurological Diseases
SBC: DRVISION TECHNOLOGIES LLC Topic: 101Project Summary Neurological disorders significantly outnumber diseases in other therapeutic areas and are growing in incidence faster than any other disease classesHoweverthe pharmaceutical industry has been unsuccessful in coming up with effective drugsA big factor in these failures has been a lack of adequate model systems for fundamental disease understanding affecting both diagnosis and treat ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Enabling point-of-care molecular diagnostics by developing an adaptive PCR instrument and on-demand kit reagents
SBC: BIOVENTURES, INC Topic: 172Because of its high sensitivitypolymerase chain reactionPCRis the gold standard for the diagnosis of many infectious diseasesbut generally only implemented in well equipped laboratoriesOne of the major roadblocks for expanding PCR to point of care markets is the lack of simplerobustsingle tube PCR designs which preserve its laboratory based high sensitivity and specificityIn this Fast Track STTR a ...
STTR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Novel therapeutic agent to prevent hearing loss during aminoglycoside therapy
SBC: Oricula Therapeutics LLC Topic: NIAIDDESCRIPTION provided by applicant Aminoglycoside antibiotics AGs are important for the treatment of a variety of serious infectious diseases including septicemia complicated intra abdominal infections complicated urinary tract infections and nosocomial respiratory tract infections AGs are the mainstay of treating Pseudomonas infection in patients with cystic fibrosis and one of the best c ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Development of Monoclonal Antibodies to Treat Pancreatic Cancer
SBC: COARE BIOTECHNOLOGY, INC. Topic: NCIAbstract Pancreatic ductal adenocarcinoma PDAC is a devastating cancer with an extremely low year survival rate even for those who are diagnosed early Novel research suggests that this may be the result of metastatic dissemination preceding or concurrent to the development of the primary tumor Epithelial mesenchymal transition EMT is one of the key pathways in pancreatic cancer invasion ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Development of Chemistry, Manufacturing, and Control Standards for PGC and PGC-dANP
SBC: PHARMAIN CORPORATION Topic: NHLBIABSTRACTThis application is seeking funding specifically for ChemistryManufacturingand ControlCMCof scale up production of long acting atrial natriuretic peptidedANPand its protected graft co polymerPGCexcipient for use in heart failureHFtreatmentThe extrinsic merit of this project will be the availability of cGMP grade PGC for use in prolonging the half life of various peptide drugs that are in p ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
A Novel Tolerance Therapeutic for Treating Multiple Sclerosis
SBC: VIRTICI LLC Topic: NIAIDOur goal is to develop VTC MSas a novel tolerance inducing therapeutic to treat Multiple SclerosisMSMS is the most common demyelinating disorder of the Central Nervous SystemCNSaffecting approximatelymillion people worldwide andin the US aloneCurrent and developing treatment of MS relies mainly on immuno suppression and modulation to reduce inflammatory symptoms creating a significant need for new ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Development of an Open Speech Signal Processing Platform
SBC: SensorLogic, Inc. Topic: NIDCDThis proposal will create an open speech signal processing platform. The open computational framework will be used for developing algorithms that will help accelerate acoustic and hearing science research. It will permit researchers to more rapidly and easily test new algorithms with greater control, performance, and ease. Several example systems will be created to show that the platform can be ad ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health